4.A new medication is being developed to treat severe nausea and vomiting among chemotherapy patients. The information below was generated from a small sample size (n = 11) and shows the number of times a chemotherapy patient vomited both before and after treatment due to the side effects of chemotherapy. Set up and interpret the results of a sign test at the alpha equals .05 level to determine if there is a difference in symptoms before and after treatment.Chemotherapy PatientBefore TreatmentAfter TreatmentDifferenceSign193 2125 3147 494 582 6113 7157 8128 978 1095 1187 A) We fail to reject H0, which states the median difference in the number of vomiting episodes in a day before and after treatment are equal because 1 is less or equal to critical value 1 for a sign test with a population of only 11 individuals.B) We fail to reject H0, which states the median difference in the number of vomiting episodes in a day before and after treatment are equal because 10 is greater or equal to the critical value 1 for a sign test with a population of only 11 individuals.C) We reject H0 in favor of H1, which states the median difference in the number of vomiting episodes in a day before and after treatment are not equal because 1 is less or equal to the critical value 1 for a sign test with a population of only 11 individuals.D) We reject H0 in favor of H1, which states the median difference in the number of vomiting episodes in a day before and after treatment are not equal because 10 is greater or equal to the critical value 1 for a sign test with a population of only 11 individuals. A researcher is conducting a study on the palliative care of patients at a specific facility to determine how their chronic pain symptoms change after entering the palliative care environment. This study is aimed at determining the effectiveness of a standardized treatment protocol for the patients entering into the palliative care environment. To do this, the researcher is comparing the pain scores of individuals before treatment and after treatment. Set up a Wilcoxon signed-ranks test and interpret it at the alpha equals .05 level.PatientBefore TreatmentAfter TreatmentValue of DifferencesOrdered Absolute Values of DifferencesRanksSign Rank194 2105 373 485 567 695 764 873 994 A) We fail to reject H0, which states the median difference in the pain scores before and after treatment are equal because 40 is less than the critical value 6 for a Wilcoxon signed-ranks test with a population of only 9 individuals.B) We fail to reject H0, which states the median difference in the pain scores before and after treatment are equal because 40 is greater than the critical value 6 for a Wilcoxon signed-ranks test with a population of only 9 individuals.C) We reject H0 in favor of H1, which states the median difference in pain scores before and after treatment are not equal because 1 is less than the critical value 6 for a Wilcoxon signed-ranks test with a population of only 9 individuals.D) We reject H0 in favor of H1, which states the median difference in pain scores before and after treatment are not equal because 1 is greater than the critical value 6 for a Wilcoxon signed-ranks test with a population of only 9 individuals

Question

4.A new medication is being developed to treat severe nausea and vomiting among chemotherapy patients. The information below was generated from a small sample size (n = 11) and shows the number of times a chemotherapy patient vomited both before and after treatment due to the side effects of chemotherapy. Set up and interpret the results of a sign test at the alpha equals .05 level to determine if there is a difference in symptoms before and after treatment.Chemotherapy PatientBefore TreatmentAfter TreatmentDifferenceSign193  2125  3147  494  582  6113  7157  8128  978  1095  1187  A) We fail to reject H0, which states the median difference in the number of vomiting episodes in a day before and after treatment are equal because 1 is less or equal to critical value 1 for a sign test with a population of only 11 individuals.B) We fail to reject H0, which states the median difference in the number of vomiting episodes in a day before and after treatment are equal because 10 is greater or equal to the critical value 1 for a sign test with a population of only 11 individuals.C) We reject H0 in favor of H1, which states the median difference in the number of vomiting episodes in a day before and after treatment are not equal because 1 is less or equal to the critical value 1 for a sign test with a population of only 11 individuals.D) We reject H0 in favor of H1, which states the median difference in the number of vomiting episodes in a day before and after treatment are not equal because 10 is greater or equal to the critical value 1 for a sign test with a population of only 11 individuals. A researcher is conducting a study on the palliative care of patients at a specific facility to determine how their chronic pain symptoms change after entering the palliative care environment. This study is aimed at determining the effectiveness of a standardized treatment protocol for the patients entering into the palliative care environment. To do this, the researcher is comparing the pain scores of individuals before treatment and after treatment. Set up a Wilcoxon signed-ranks test and interpret it at the alpha equals .05 level.PatientBefore TreatmentAfter TreatmentValue of DifferencesOrdered Absolute Values of DifferencesRanksSign Rank194    2105    373    485    567    695    764    873    994    A) We fail to reject H0, which states the median difference in the pain scores before and after treatment are equal because 40 is less than the critical value 6 for a Wilcoxon signed-ranks test with a population of only 9 individuals.B) We fail to reject H0, which states the median difference in the pain scores before and after treatment are equal because 40 is greater than the critical value 6 for a Wilcoxon signed-ranks test with a population of only 9 individuals.C) We reject H0 in favor of H1, which states the median difference in pain scores before and after treatment are not equal because 1 is less than the critical value 6 for a Wilcoxon signed-ranks test with a population of only 9 individuals.D) We reject H0 in favor of H1, which states the median difference in pain scores before and after treatment are not equal because 1 is greater than the critical value 6 for a Wilcoxon signed-ranks test with a population of only 9 individuals

Accepted Answer

Hello! As you have posted 2 different questions, we are answering the first question. In case you…

Patient	Before Treatment	After Treatment	Value of Differences	Ordered Absolute Values of Differences	Ranks	Sign Rank
1	9	4
2	10	5
3	7	3
4	8	5
5	6	7
6	9	5
7	6	4
8	7	3
9	9	4

Chemotherapy Patient	Before Treatment	After Treatment	Difference	Sign
1	9	3
2	12	5
3	14	7
4	9	4
5	8	2
6	11	3
7	15	7
8	12	8
9	7	8
10	9	5
11	8	7